OOIR: Observatory of International Research

Papers

(The TQCC of Immunology and Allergy Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Allergic Rhinitis in Children and Adolescents	43
Anaphylaxis and Mast Cell Disorders	29
Global Climate Change and Pollen Aeroallergens	28
Racial/Ethnic Differences in Food Allergy	25
Biologics for the Treatment of Allergic Rhinitis, Chronic Rhinosinusitis, and Nasal Polyposis	25
The Role of Extreme Weather and Climate-Related Events on Asthma Outcomes	23
Innate Immunity	22
Dietary Management of Food Allergy	21
Genetics of Food Allergy	21
The Impact of Climate Change on Pollen Season and Allergic Sensitization to Pollens	18
Biologics for the Treatment of Allergic Conditions: Eosinophil Disorders	18
Climate Change and Pollen Allergy in India and South Asia	16
Targeting Mast Cells with Biologics	15
Air Pollution Effects in Allergies and Asthma	15
Skin Testing Approaches for Immediate and Delayed Hypersensitivity Reactions	14
Monoclonal Antibodies (Biologics) for Allergic Rhinitis, Asthma, and Atopic Dermatitis During Pregnancy and Lactation	13
The Who, What, Where, When, Why, and How of Drug Desensitization	13
The Role of Smoking in Asthma and Chronic Obstructive Pulmonary Disease Overlap	13
Biologics and Novel Therapies for Food Allergy	12
Biologics for Atopic Dermatitis	12
Contact Urticaria	12
Anaphylaxis	11
Perioperative Anaphylaxis	11
Climate Change, Air Pollution, and Biodiversity in Asia Pacific and Impact on Respiratory Allergies	11
The Infant Microbiome and Its Impact on Development of Food Allergy	10

Biologics and Allergy Immunotherapy in the Treatment of Allergic Diseases	10
Psychosocial Aspects of Food Allergy	9
Biologics for the Treatments of Allergic Conditions	9
Mas-Related G Protein–Coupled Receptor-X2 and Its Role in Non-immunoglobulin E–Mediated Drug Hypersensitivity	9
Allergy to Radiocontrast Dye	9
Pediatric Drug Allergy	9
Recognizing Drug Hypersensitivity in Pigmented Skin	9
New Insights and Treatments in Atopic Dermatitis	9
Immune-Related Adverse Drug Reactions and Immunologically Mediated Drug Hypersensitivity	9
Innate Immune Regulation of Dermatitis	8
Management of Anaphylaxis	8
Systemic Allergic Reactions and Anaphylaxis Associated with Allergen Immunotherapy	8
Insect Migration and Changes in Venom Allergy due to Climate Change	8
Pediatric Allergic Contact Dermatitis	8
Eosinophilic Lung Diseases	8
Anaphylaxis to Excipients in Current Clinical Practice	8
Pharmacogenomics of Drug Hypersensitivity	8
Effect of Climate Change on Allergenic Airborne Pollen in Japan	8
Anaphylaxis in Children and Adolescents	8
Climate Change Factors and the Aerobiology Effect	7
Diagnosis and Management of Food Allergy	7
Anaphylaxis	7
World Health Organization Classification and Diagnosis of Mastocytosis	7
Phenotypes of Asthma–Chronic Obstructive Pulmonary Disease Overlap	7
Anaphylaxis	7
Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis	7
The Unmet Needs of Patients with Food Allergies	7
Advances in the Pathomechanisms of Delayed Drug Hypersensitivity	7
Pathophysiology of Immunologic and Nonimmunologic Systemic Reactions Including Anaphylaxis	7
Newborn Screening for Severe Combined Immunodeficiency	6
Anaphylaxis to Stinging Insect Venom	6
Drug Hypersensitivity Reactions	6
Allergenic Pollen Season Variations in the Past Two Decades Under Changing Climate in the United States	6
Eosinophilic Esophagitis	6
Sarcoidosis	5
Occupational Interstitial Lung Diseases	5
Biologics for the Treatment of Food Allergies	5
Biologic Agents for the Treatment of Anaphylaxis	5
Viral Infections and Wheezing in Preschool Children	5
Current and Potential Biologic Drugs for the Treatment of Chronic Urticaria	5
Post-COVID Interstitial Lung Disease—The Tip of the Iceberg	5
KIT Mutations and Other Genetic Defects in Mastocytosis	5
Mimics of Dermatitis	5
Asthma-Chronic Obstructive Pulmonary Disease Overlap	5
Hereditary Angioedema	5
Chronic Management of Asthma During Pregnancy	5
The Use of Electronic Health Records to Study Drug-Induced Hypersensitivity Reactions from 2000 to 2021	5
A Risk-Based Approach to Penicillin Allergy	4
Spondyloarthritides	4
Climate Change and Extreme Weather Events in Australia	4

Sarcoidosis	4
Measuring Symptom Severity and Quality of Life in Mastocytosis	4
Recognition and Management of Food Allergy and Anaphylaxis in the School and Community Setting	4
Environmental Exposures Impact Pediatric Asthma Within the School Environment	4
Drug-Induced Interstitial Lung Diseases	4
Ozone in the Development of Pediatric Asthma and Atopic Disease	4
Hypersensitivity Reactions and Immune-Related Adverse Events to Immune Checkpoint Inhibitors: Approaches, Mechanisms, and Models	4
Anaphylaxis to Drugs, Biological Agents, and Vaccines	4
Drug and Venom Allergy in Mastocytosis	4
Tackling Food Allergy in Infancy	4
Forecast for Pollen Allergy	4
Smoking-Related Interstitial Lung Diseases	4
Influence of Rural Environmental Factors in Asthma	4